Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 4 , Pages 652-659 , April 2008

Use of Goal Attainment Scaling in Inpatient Rehabilitation for Persons With Multiple Sclerosis

  • Fary Khan, MBBS, FAFRM (RACP)

      Affiliations

    • Department of Rehabilitation Medicine, University of Melbourne, and Royal Melbourne Hospital, Melbourne VIC, Australia
    • Corresponding Author InformationCorrespondence to Fary Khan, MBBS, FAFRM (RACP), Dept of Rehabilitation Medicine, University of Melbourne, Neurological Rehabilitation Physician-Royal Melbourne Hospital, Poplar Rd, Parkville, Melbourne, VIC 3052, Australia
  • ,
  • Julie F. Pallant, PhD

      Affiliations

    • School of Rural Health, University of Melbourne, Melbourne VIC, Australia
  • ,
  • Lynn Turner-Stokes, MBBS, MA, DM, FRCP

      Affiliations

    • Herbert Dunhill Chair of Rehabilitation, Kings College London, UK.

References 

  1. Programme for Neurological Diseases and Neurosciences, Department of Mental Health and Substance Abuse, World Health Organization. Atlas: country resources for neurological disorders (Results of a collaborative study of World Health Organization and World Federation of Neurology). Geneva: WHO; 2004;http://www.who.int/mental_health/neurology/neurogy_atlas_lr.pdfAccessed Feb 2, 2006
  2. Khan F, Turner Stokes L, Ng L, Kilpatrick T. Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database Syst Rev. 2007;2:CD006036
  3. Whyte J. Traumatic brain injury rehabilitation: are there alternatives to randomized clinical trials?. Arch Phys Med Rehabil. 2002;83:1320–1322
  4. Thompson AJ. The effectiveness of neurological rehabilitation in multiple sclerosis. J Rehabil Res Dev. 2000;37:455–461
  5. Uniform Data System for Medical Rehabilitation. Guide for use of the Uniform Data System for medical rehabilitation (adult FIM) (Version 4). Buffalo: Research Foundation, State Univ New York; 1995;
  6. Mahoney FI, Barthel D. Functional evaluation: the Barthel index. Md State Med J. 1965;14:56–61
  7. Wade DT. Evidence relating to goal planning in rehabilitation. Clin Rehabil. 1998;12:273–275
  8. Kirusek TJ, Sherman RE. Goal Attainment Scaling: a general method for evaluating comprehensive community mental health programs. Community Ment Health J. 1968;4:443–453
  9. Rushton PW, Miller WC. Goal attainment scaling in the rehabilitation of patients with lower extremity amputations: a pilot study. Arch Phys Med Rehabil. 2002;83:771–775
  10. Rockwood K, Joyce B, Stolee P. Use of goal attainment scaling in measuring clinically important change in cognitive rehabilitation patients. J Clin Epidemiol. 1997;50:581–588
  11. Stolee P, Rockwood K, Fox RA, Streiner DL. The use of goal attainment scaling in a geriatric care setting. J Am Geriatr Soc. 1992;40:574–578
  12. Rockwood K, Stolee P, Fox RA. Use of goal attainment scaling in measuring clinically important change in the frail elderly. J Clin Epidemiol. 1993;46:1113–1118
  13. Joyce BM, Rockwood KJ, Mate-Kole CC. Use of goal attainment scaling in brain injury in a rehabilitation hospital. Am J Phys Med Rehabil. 1994;73:10–14
  14. Ashford S, Turner Stokes L. Goal attainment for spasticity management using botulinum toxin. Physiother Res Int. 2006;11:24–34
  15. Hurn J, Kneebone I, Cropley M. Goal setting as an outcome measure: a systematic review. Clin Rehabil. 2006;20:756–772
  16. Stuifbergen AK, Becker H, Timmerman GM, Kullberg V. The use of individualized goal setting to facilitate behaviour change in women with multiple sclerosis. J Neurosci Nurs. 2003;35:94–99
  17. Khan F, McPhail T, Brand C, Turner-Stokes L, Kilpatrick T. Multiple sclerosis: disability profile and quality of life in multiple sclerosis in an Australian community cohort. Int J Rehabil Res. 2006;29:87–96
  18. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;3:227–231
  19. Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT neurology. Neurology. 1988;38:180–185
  20. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–1452
  21. Granger CV, Cotter AC, Hamilton BB, Fiedler RC, Hens MM. Functional assessment scales: a study of persons with multiple sclerosis. Arch Phys Med Rehabil. 1990;71:870–875
  22. National Institute of Mental Health. CGI: Clinical Global Impressions. In:  Guy W,  Bonato RR editor. Manual for the ECDEU Assessment Battery. 2nd rev ed.. Chevy Chase: National Institute of Mental Health; 1970;p. 12-1–12-6
  23. Khan A, Khan SR, Shankles EB, Polissar NL. Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression Rating Scale and the Clinical Global Impressions rating scale in antidepressant clinical trials. Int Clin Psychopharmacol. 2002;17:281–285
  24. Rockwood K, Howlett S, Stadnyk K, Carver D, Powell C, Stolee P. Responsiveness of goal attainment scaling in a randomized controlled trial of comprehensive geriatric assessment. J Clin Epidemiol. 2003;56:736–743
  25. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? (A comparison with some other self report scales). J Neurol Neurosurg Psychiatry. 2005;76:1539–1543
  26. World Health Organization. International classification of functioning, disability and health: ICF. Geneva: WHO; 2001;
  27. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study (2. Predictive value of early clinical course). Brain. 1989;112(Pt 6):1419–1428
  28. MacAllister WS, Krupp LB. Multiple sclerosis related fatigue. Phys Med Rehabil Clin N Am. 2005;16:483–502
  29. Fischer JS. Cognitive impairment in multiple sclerosis. In:  Cook SD editors. Handbook of multiple sclerosis. 3rd ed.. New York: Marcel Dekker; 2001;p. 233–255
  30. Reitberg MB, Brooks D, Uitdehaag BM, Kwakkel G. Exercise therapy for multiple sclerosis. Cochrane Database Syst Rev. 2005;1:CD003980
  31. Brown TR, Kraft GH. Exercise and rehabilitation for individuals with multiple sclerosis. Phys Med Rehabil Clin N Am. 2005;16:513–556
  32. Nicholas RS, Friede T, Hollis S, Young CA. Anticholinergics for urinary symptoms in multiple sclerosis. Cochrane Database Syst Rev. 2003;2:CD004193
  33. Borello-France D, Leng W, O’Leary M, et al. Bladder and sexual function among women with multiple sclerosis. Mult Scler. 2004;10:455–461
  34. Becker H, Stuifbergen A, Rogers S, Timmerman G. Goal attainment scaling to measure individual change in intervention studies. Nurs Res. 2000;49:176–180
  35. Jones MC, Walley RM, Leech A, Paterson M, Common S, Metcalf C. Using goal attainment scaling to evaluate a needs-led exercise programme for people with severe and profound intellectual disabilities. J Intellect Disabil. 2006;10:317–335
  36. Hobart J, Lamping D, Fitzgerald R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS): a new patient based outcome measure. Brain. 2001;124:962–973

 Supported by the Luff Foundation and the Dunhill Medical Trust.

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors or upon any organization with which the authors are associated.

 Reprints are not available from the author.

PII: S0003-9993(08)00028-2

doi: 10.1016/j.apmr.2007.09.049

Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 4 , Pages 652-659 , April 2008